Antibiotics Market Size & Share, by Drug Class (Beta Lactam & Beta Lactamase Inhibitors, Macrolide); Drug Origin (Natural, Semisynthetic, Synthetic); Spectrum of Activity (Broad-Spectrum, Narrow-Spectrum); Indication (Skin Infections, Respiratory, Gastrointestinal, UTIs, Blood Stream, Clostridium Difficile, Ear Infections); End-user (Hospitals, Specialty Clinics) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4465
  • Published Date: Feb 13, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2023-2035

Antibiotics Market size is estimated to surpass USD 108 billion by the end of 2035, growing at a CAGR of 8% during the forecast period, i.e., 2023-2035. In the year 2022, the industry size of antibiotics was over USD 43 billion. The growth of the market is primarily attributed to the worldwide growing prevalence of various communicable diseases, such as TB, HIV, and others. As per the World Health Organization (WHO) statistics, in 2020, an estimated 1.5 million (UI 1.0 to 2.0 million) people were infected with HIV for the first time. This brought the global HIV population to 38.4 million people by 2021.

Antibiotics are antibacterial compounds that are active against bacteria. It is the most common type of antibacterial agent used to treat bacterial infections. Antibiotic medications are commonly used to treat and prevent such infections. They either kill or inhibit bacterial growth. Such factor is leading up the growing consumption of various types of antibiotics across the globe. For instance, global antibiotic consumption rates surged by 47% between 2000 and 2018 (from 9.8 to 14.3 defined daily doses (DDD) per 1000 people per day).


Antibiotics Market
Get more information on this report: Request Free Sample PDF

Antibiotics Sector: Growth Drivers and Challenges

Growth Drivers

  • Growing Prevalence of Respiratory Diseases - The respiratory system is a group of organs that regulates breathing. The lungs are the system's main organ, and it also consists of the pharynx, larynx, trachea, nasal tube, oral cavity, pharynx, and bronchi and bronchioles. Respiratory diseases are one of the leading causes of death worldwide. These diseases need a preferred dose of antibiotics to control the further spread of bacteria. Therefore, growing prevalence of respiratory diseases is fueling up the antibiotics market growth. As per the World Health Organization statistics, globally, nearly 262 million individuals have been suffering from asthma.
  • Surge in Drug Combinations Over Mono-Therapy – It was observed in a clinical study that a database for antifungal therapy has nearly 5,517 medicines in 8,129 combinations that have been evaluated against 240 strains, yielding 491,126 samples.
  • Escalation in Urinary Tract Infections (UTIs) – For instance, every year, more than 8 million patients with urinary tract infections (UTIs) seek medical treatment. About 61% of women and 13% of men are predicted to get at least one UTI in their lives.
  • Boost in Global Burden of Bacterial Skin Diseases – Globally, the age-standardized estimated incidence of bacterial skin diseases was reached around 161 million for males and 133 million for females in 2019.
  • Growing Number of Older-Aged Population - According to the statistics of World Health Organization, the global population of people aged 60 and up is projected to increase from 1 billion in 2020 to 1.4 billion by 2030.

Challenges

  • Side Effects Associated with Antibiotics - Antibiotic side effects can include allergic reactions and severe, sometimes fatal diarrhea brought on by the bacterium Clostridium difficile (C. diff). Additionally, antibiotics may conflict with other medications.
  • Stringent Regulatory Procedures
  • Escalation in Antibiotic Resistance

Antibiotics Market: Key Insights

Base Year

2022

Forecast Year

2023-2035

CAGR

~8%

Market Size in Base Year (2022)

~ USD 43 Billion

Market Size in Forecast Year (2035)

~ USD 108 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Antibiotics Segmentation

Indication (Skin Infections, Respiratory, Gastrointestinal, UTIs, Blood Stream, Clostridium Difficile, Ear Infections)

The global antibiotics market is segmented and analyzed for demand and supply by indication into skin infections, respiratory, gastrointestinal, UTIs, blood stream, clostridium difficile, ear infections, and others. Out of these, the gastrointestinal segment is projected to significantly grow over the forecast period on the back of increasing prevalence of acute infectious diarrhea in children across the globe. For instance, acute infectious diarrhea is one of the most serious conditions in the world and is accountable for 1 million to 2.5 million deaths per year. Globally, more than 2 to 5 billion kids are affected every year.

Our in-depth analysis of the global market includes the following segments:

        By Drug Class

  • Beta Lactam & Beta Lactamase Inhibitors
  • Macrolide
  • Others

        By Drug Origin

  • Natural
  • Semisynthetic
  • Synthetic

        By Spectrum of Activity

  • Broad-Spectrum
  • Narrow-Spectrum Antibiotics

 

          By Indication

  • Skin Infections
  • Respiratory
  • Gastrointestinal
  • UTIs
  • Blood Stream
  • Clostridium Difficile
  • Ear Infections
  • Others

         By End-User

  • Hospitals
  • Specialty Clinics
  • Others

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Antibiotics Industry - Regional Synopsis

APAC Market Statistics

The Asia Pacific antibiotics market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2035. It is backed by the growing prevalence of infectious diseases, increasing consumption of antibiotics by regional population, significantly growing population, and growing healthcare expenditure in the region. For instance, around 4.2 billion people, or 61% of the world's population, reside in the Asia Pacific region.

Research Nester
Antibiotics Market Size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Antibiotics Landscape

top-features-companies
    • F. Hoffmann-La Roche Ltd.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • GlaxoSmithKline plc
    • Bristol-Myers Squibb Company
    • Teva Pharmaceuticals Industries Ltd.
    • Pfizer Inc.
    • Abbott Laboratories
    • Merck & Co., Inc.
    • Lupin Limited
    • Melinta Therapeutics, LLC
    • Bayer AG  

In-the-news

In The News

  • GlaxoSmithKline plc and Spero Therapeutics have announced an exclusive license agreement for tebipenem pivoxil hydrobromide (tebipenem HBr), a late-stage antibiotic that is anticipated to be used to treat complex urinary tract infections. Its 3rd phase clinical trial is estimated to start in 2023.

  • Teva Pharmaceuticals Industries Ltd. announced the launch of its 250 mg and 500 mg strength generic Erythromycin tablets as a therapeutic equivalent to Arbor Pharmaceuticals' reference listed drug (RLD) Erythromycin Tablets. A variety of bacterial infections and rheumatic fever attacks are projected to be treated with these tablets in patients allergic to penicillin.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4465
  • Published Date: Feb 13, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Growing prevalence of respiratory diseases, surge in drug combinations over mono-therapy, escalation in urinary tract infections (UTIs) are some major factors driving the growth of the market.

The market is anticipated to attain a CAGR of 8% over the forecast period, i.e., 2023-2035.

Side effects associated with antibiotics, stringent regulatory procedures, and escalation in antibiotic resistance are estimated to hamper the market growth.

The market in Asia Pacific is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Bristol-Myers Squibb Company, Teva Pharmaceuticals Industries Ltd., Pfizer Inc., Abbott Laboratories, Merck & Co., Inc., and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by drug class, drug origin, spectrum of activity, indication, end-user, and by region.

The gastrointestinal segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Antibiotics Market Report Scope
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying